0001022079-17-000122.txt : 20170426
0001022079-17-000122.hdr.sgml : 20170426
20170426163443
ACCESSION NUMBER: 0001022079-17-000122
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170424
FILED AS OF DATE: 20170426
DATE AS OF CHANGE: 20170426
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRITELL JENNE K
CENTRAL INDEX KEY: 0001142318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 17784855
MAIL ADDRESS:
STREET 1: 100 FIRST STAMFORD PLACE
STREET 2: SUITE 700
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
wf-form4_149323886844998.xml
FORM 4
X0306
4
2017-04-24
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001142318
BRITELL JENNE K
C/O QUEST DIAGNOSTICS
3 GIRALDA FARMS
MADISON
NJ
07940
1
0
0
0
Common Stock
2017-04-24
4
M
0
6111
57.67
A
25996
I
by Trust
Common Stock
2017-04-24
4
S
0
6111
104.03
D
19903
I
by Trust
Stock Options (Right to Buy)
57.67
2017-04-24
4
M
0
6111
57.67
D
2021-05-17
Common Stock
6111.0
0
I
by Trust
This transaction was executed in multiple trades at prices ranging from $104.008 to $104.060. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
The options vested in three equal annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014.
/s/William J. O'Shaughnessy, Jr., Attorney in Fact for Jenne K. Britell
2017-04-26